ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Rosenberg’s Gene Transfer Protocol Approved By NIH Advisory Group

October 7, 1988

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

In Brief: NCCR Presents Gold Medal To Sen. Karkin; DCT Recruits Okunieff For Radiation Oncology

February 26, 1993

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

In Brief: Mary Lasker To Be Named To NIH Director’s Advisory Committee; Amos Appointment Official

July 18, 1980

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012